Popular antidepressant recalled for high levels of a potentially cancer-causing chemical - KOLN
Breckenridge Pharmaceuticals is recalling nearly 375,000 bottles of duloxetine nationwide. Tests found elevated levels of a nitrosamine impurity that may cause cancer. The drug is a generic version of Cymbalta used for depression, anxiety, and fibromyalgia.
What changed
The manufacturer is identified as New Jersey-based Breckenridge Pharmaceuticals and the chemical is identified as a nitrosamine impurity.
Live updates
-
Breckenridge Pharmaceuticals Recalls Duloxetine Over Cancer-Causing Impurity
confidence 100%Breckenridge Pharmaceuticals is recalling nearly 375,000 bottles of duloxetine nationwide. Tests found elevated levels of a nitrosamine impurity that may cause cancer. The drug is a generic version of Cymbalta used for depression, anxiety, and fibromyalgia.
What's confirmed:
- Nearly 375,000 bottles of duloxetine are being recalled nationwide.
- The recall was triggered by elevated levels of a potentially cancer-causing nitrosamine impurity.
- The drug is used to treat anxiety, depression, and fibromyalgia.
- Breckenridge Pharmaceuticals is the New Jersey-based company recalling the generic version of Cymbalta.
-
FDA Announces Recall of Popular Antidepressant Over Carcinogen Risk
confidence 100%The FDA announced a recall of a common antidepressant due to high levels of a potentially cancer-causing chemical. The medication is used to treat anxiety, depression, and fibromyalgia. Nearly 375,000 bottles are affected.
What's confirmed:
- The FDA announced a recall of a popular antidepressant due to a possible carcinogen risk.
- The recall involves nearly 375,000 bottles of the medication.
- The drug is used to treat fibromyalgia, anxiety, and depression.
- The distributor voluntarily recalled the medication after detecting high levels of a potentially cancer-causing chemical.